Goubareva N N, Fedorova N V, Bril' E V, Tomskiy A A, Gamaleya A A, Poddubskaya A A, Shabalov V A, Omarova S M
Russian Medical Academy of Postgraduate Education, Centre for Extrapyramidal Disorders, Moscow, Russia.
Burdenko National Research Neurosurgery Institute, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(11):24-30. doi: 10.17116/jnevro201711711124-30.
To evaluate the efficacy of deep brain stimulation in the subthalamic nucleus (DBS STN) in patients with Parkinson's disease (PD) using different methods of targeting according to the dynamics of motor symptoms of PD.
The study involved 90 patients treated with DBS STN. In 30 cases intraoperative microelectrode recording (MER) was used. MER was not performed in 30 patients of the comparison group. The control group consisted of 30 patients with PD who received conservative treatment. Hoehn and Yahr scale, Tinetti Balance and Mobility Scale (TBMS), Unified Parkinson's Disease Rating Scale (UPDRS), Parkinson's Disease Quality of Life-39 Scoring System (РDQ-39), Schwab & England ADL Scale were used. Levodopa equivalent daily dose (LEDD, 2010) was calculated for each patient.
The effect of DBS STN using intraoperative microelectrode recording on the main motor symptoms, motor complications, walking as well as indicators of quality of life and daily activities was shown. In both DBS STN groups, there was a significant reduction in the LEDD and marked improvement of the control of motor symptoms of PD. A significant reduction in the severity of motor fluctuations (50%) and drug-induced dyskinesia (51%) was observed. Quality of life and daily activity in off-medication condition were significantly improved in both DBS STN groups of patients, irrespective of the method of target planning (75-100%), compared with the control group.
根据帕金森病(PD)运动症状的动态变化,采用不同的靶点定位方法,评估丘脑底核深部脑刺激术(DBS-STN)对帕金森病患者的疗效。
本研究纳入90例接受DBS-STN治疗的患者。其中30例术中使用微电极记录(MER)。对照组30例患者未进行MER。对照组由30例接受保守治疗的PD患者组成。采用Hoehn和Yahr量表、Tinetti平衡与运动量表(TBMS)、统一帕金森病评定量表(UPDRS)、帕金森病生活质量-39评分系统(PDQ-39)、施瓦布与英格兰日常生活活动量表。计算每位患者的左旋多巴等效日剂量(LEDD,2010)。
显示了术中使用微电极记录的DBS-STN对主要运动症状、运动并发症、步行以及生活质量和日常活动指标的影响。在两个DBS-STN组中,LEDD均显著降低,PD运动症状的控制明显改善。观察到运动波动严重程度(50%)和药物性异动症(51%)显著降低。与对照组相比,两个DBS-STN组患者在非服药状态下的生活质量和日常活动均有显著改善,无论靶点规划方法如何(75-100%)。